Piper Sandler Lowers Moderna Price Target Amid Challenges but Sees Long-Term Potential
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameModerna, Inc.
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









